While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more.

(Bloomberg) -- Selecta Group BV and a group of its bondholders asked a federal judge to dismiss a lawsuit accusing them of violating US antitrust laws as creditors made a pact among themselves to ...

Selecta Biosciences recently announced the results of its DISSOLVE I & II Phase 3 clinical trials for SEL-212, a combination therapy for chronic refractory gout patients. The trials met their primary ...